EASL supports new COVID-Hep registry on patients with COVID-19
EASL encourages healthcare professionals to share the EASL supported COVID-Hep registry among its networks. The registry was launched at the University of Oxford, UK in March 2020, to collect data on patients,…
Review summarises liver injury from human coronavirus infections, including SARS-CoV-2
A review published in Liver International journal summarises the characteristics and mechanism of liver injury caused by three highly pathogenic human coronavirus infections: severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory…
EASL postpones ILC 2020 until August
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and…
US Task Force issues recommendation on screening adults aged 18-79 for hepatitis C, no matter their risk
On 2 March 2020, the U.S. Preventive Services Task Force published a final recommendation statement on screening for hepatitis C virus (HCV) infection in adolescents and adults. It recommends screening all adults…
Journal of Hepatology call for papers on COVID-19
Following the initiative of other leading scientific journals, we believe that it is timely, important, and appropriate to share as soon as possible with our Journal of Hepatology readers all information available…
Joint Statement I Prevention at the heart of Europe’s Beating Cancer Plan
Europe’s Beating Cancer Plan needs a thorough prevention pillar to tackle challenges common to all non-communicable diseases (NCDs), reads a statement by 30+ health organisations. NCDs, such as cardiovascular disease, cancer, respiratory…
Experts discuss latest research and future of liver cancer
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the…